Evotec SE Logo

Evotec SE (EVT)

XETR

Currency in EUR
2.81
-0.13 (-4.36%)

Closed

Oct 8, 2026

Day's Range

2.77
2.93

52 wk Range

2.71
7.30

Overview - EVT - Evotec SE

Key Statistics

Valuation

Enterprise Value

529.08M

P/E (Trailing)

‪-5.03‬

P/E (Forward)

‪-6.99‬

PEG Ratio

‪-6.99‬

Price / Sales (TTM)

‪0.72‬

Price / Book

‪0.77‬

EV / EBITDA

‪-7.23‬

Profitability

Gross Margin

‪-1.10%‬

Profit Margin

‪-27.47%‬

Operating Margin

‪-62.25%‬

Return on Assets

‪-5.39%‬

Return on Equity

‪-26.07%‬

Ownership

Shares Outstanding

177.59M

Float

135.49M

Held by Insiders

‪9.96%‬

Held by Institutions

‪62.11%‬

Price stats

Beta

‪1.26‬

50-Day Avg

‪3.22‬

200-Day Avg

‪4.68‬

Dividends

Payout Ratio

‪0.00%‬

Analyst Consensus

Hold

8 analysts

Average price target

‪€ 4.59‬

News Teaser - EVT - Evotec SE

News & Analysis

View all news

Market Cap - EVT - Evotec SE

Peers - EVT - Evotec SE

Peer Comparison

Compared with companies in Drug Manufacturers - Specialty & Generic listed on XETR.

Profile Summary - EVT - Evotec SE

About

Evotec SE is a leading life science company specializing in drug discovery and development for pharmaceutical and biotechnology partners. Founded in 1993 in Hamburg, Germany, it operates through two key segments: EVT Execute, which delivers integrated drug discovery solutions on a fee-for-service basis or via…

SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
Employees4.46K
Full company profile

The information on this page is provided for general informational purposes only and is not investment advice.

Market data provided by Twelve Data. Charting by TradingView.

Last updated:

Track Global Markets in Real Time with UA Finance

Download the app now and access live financial data, expert analysis, and trusted economic news to follow stocks, forex, gold, and cryptocurrencies with ease.